304 related articles for article (PubMed ID: 16206071)
21. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of serum soluble Fas, Fas ligand and fas in intrahepatic lymphocytes in chronic hepatitis C.
Zaki Mel S; Auf FA; Ghawalby NA; Saddal NM
Immunol Invest; 2008; 37(2):163-70. PubMed ID: 18300041
[TBL] [Abstract][Full Text] [Related]
23. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
Bonnard P; Lescure FX; Amiel C; Guiard-Schmid JB; Callard P; Gharakhanian S; Pialoux G
J Viral Hepat; 2007 Nov; 14(11):806-11. PubMed ID: 17927617
[TBL] [Abstract][Full Text] [Related]
24. [Hepatitis and posthepatic cirrhosis in AIDS].
Bierhoff E; Fischer HP; Pfeifer U; Rockstroh J; Spengler U
Verh Dtsch Ges Pathol; 1995; 79():249-53. PubMed ID: 8600688
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver disease.
Sterling RK; Lyons CD; Stravitz RT; Luketic VA; Sanyal AJ; Carr ME; Smith TJ; Hackney MH; Contos MJ; Mills SA; Kuhn JG; Nolte ME; Shiffman ML
Haemophilia; 2007 Mar; 13(2):164-71. PubMed ID: 17286769
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection?
Bäuerle J; Laguno M; Mauss S; Mallolas J; Murillas J; Miquel R; Schmutz G; Setzer B; Gatell JM; Walker UA
HIV Med; 2005 Mar; 6(2):135-9. PubMed ID: 15807720
[TBL] [Abstract][Full Text] [Related]
28. Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: a longitudinal evaluation.
Antonucci G; Vairo F; Iacomi F; Comandini UV; Solmone M; Piselli P; Boumis E; Lauria FN; Capobianchi MR; Ippolito G; Puro V
Scand J Infect Dis; 2008; 40(11-12):928-34. PubMed ID: 18651264
[TBL] [Abstract][Full Text] [Related]
29. Concentrations of ssDNA in liver tissue and its correlation with sFas and sFasL in serum of patients infected with HBV, HCV, HCV and HIV.
Łapinski TW; Wiercińska-Drapało A; Panasiuk A; Kovalchuk O
Adv Med Sci; 2007; 52():109-13. PubMed ID: 18217400
[TBL] [Abstract][Full Text] [Related]
30. Concentrations of soluble Fas and soluble Fas ligand as indicators of programmed cell death among patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
Lapinski TW; Jaroszewicz J; Wiercinska-Drapalo A
Viral Immunol; 2006; 19(3):570-5. PubMed ID: 16987075
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.
Bonnet F; Pineau JJ; Taupin JL; Feyler A; Bonarek M; de Witte S; Bernard N; Lacoste D; Morlat P; Beylot J
J Rheumatol; 2003 Sep; 30(9):2005-10. PubMed ID: 12966606
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus.
Hull MW; Rollet K; Odueyungbo A; Saeed S; Potter M; Cox J; Cooper C; Gill J; Klein MB;
Clin Infect Dis; 2012 Jun; 54(12):1798-805. PubMed ID: 22460964
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002.
Schiavini M; Angeli E; Mainini A; Zerbi P; Duca PG; Gubertini G; Vago L; Fociani P; Giorgi R; Cargnel A
HIV Med; 2006 Jul; 7(5):331-7. PubMed ID: 16945079
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.
Pineda JA; González J; Ortega E; Tural C; Macías J; Griffa L; Burgos A;
J Viral Hepat; 2010 Oct; 17(10):714-9. PubMed ID: 20002560
[TBL] [Abstract][Full Text] [Related]
35. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
[TBL] [Abstract][Full Text] [Related]
36. Association among Fas expression in leucocytes, serum Fas and Fas-ligand concentrations and hepatic inflammation and fibrosis in chronic hepatitis C.
Panasiuk A; Parfieniuk A; Zak J; Flisiak R
Liver Int; 2010 Mar; 30(3):472-8. PubMed ID: 19919570
[TBL] [Abstract][Full Text] [Related]
37. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
Schwarze-Zander C; Blackard JT; Zheng H; Addo MM; Lin W; Robbins GK; Sherman KE; Zdunek D; Hess G; Chung RT;
J Infect Dis; 2006 Aug; 194(4):410-9. PubMed ID: 16845623
[TBL] [Abstract][Full Text] [Related]
38. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
39. Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus.
Roe B; Hall WW
Expert Rev Mol Med; 2008 Oct; 10():e30. PubMed ID: 18928579
[TBL] [Abstract][Full Text] [Related]
40. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
